Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2709 USD | +4.23% |
|
-5.84% | +61.25% |
06-11 | BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion | CI |
05-14 | Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Business Summary
Number of employees: 32
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Odor-No-More Environmental
93.5
%
| 4 | 74.3 % | 11 | 93.5 % | +161.55% |
BioLargo Engineering, Science & Technologies
19.6
%
| 2 | 33.0 % | 2 | 19.6 % | +23.37% |
Intersegment
-13.5
%
| 0 | -8.4 % | -2 | -13.5 % | +234.75% |
BioLargo Canada
0.2
%
| 0 | 0.0 % | 0 | 0.2 % | +2,900.00% |
Clyra Medical
0.2
%
| 0 | 1.0 % | 0 | 0.2 % | -64.29% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 12 | 100.0 % | +107.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Charles Dargan
DFI | Director of Finance/CFO | 68 | 08-01-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Mitch Noto
PRN | Corporate Officer/Principal | - | - |
Tonya Chandler
SAM | Sales & Marketing | - | - |
A. J. Sexton
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Jack Strommen
BRD | Director/Board Member | 54 | 17-05-31 |
Linda Park
BRD | Director/Board Member | 46 | 22-10-31 |
Christina Bray
BRD | Director/Board Member | 36 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 296,839,523 | 254,710,274 ( 85.81 %) | 0 | 85.81 % |
Company contact information
![address BioLargo, Inc.(BLGO)](https://cdn.zonebourse.com/static/address/120791837.png)
Sales per Business
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.25% | 80.52M | |
+2.11% | 101B | |
-11.98% | 58.77B | |
+72.38% | 47.81B | |
+8.17% | 35.9B | |
+0.79% | 31.2B | |
+4.32% | 18.77B | |
+13.88% | 16.92B | |
+5.77% | 13.49B | |
-5.51% | 12.88B |
- Stock Market
- Equities
- BLGO Stock
- Company BioLargo, Inc.